| Name | Title | Contact Details |
|---|
The Kraft Heinz Company, commonly known as Kraft Heinz, is an American multinational food company formed by the merger of Kraft Foods and Heinz co-headquartered in Chicago and Pittsburgh.
We`re rethinking everything. Starting with food. We believe humans can do the right thing – the best thing, even. And when we work with nature, together we can build a future that`s better for everything. Using safe, proven fermentation methods we make animal-free whey protein from microflora – not cows – to make dairy that`s identical to traditional milk. Now, you can enjoy the foods you love without compromising our climate future. It`s dairy that`s better for everything.
The Stoller Group now includes 15 wholly owned subsidiaries with more than 1.000 employees in more than 50 countries around the world.
Sauers is a company that sells a variety of food products including spices, herbs, flavorings, mayonnaise, pourable salad dressings, condiments, sauces, and extracts.
Neptune is a biotechnology company engaged primarily in the development and commercialization of marine-derived omega-3 polyunsaturated fatty acids ("PUFAs"). Neptune has a patented process of extracting oils from Antarctic krill, and principally sells omega-3 PUFAs as bulk oil to Neptune`s distributors who commercialize them under their private label primarily in the U.S., European and Australian nutraceutical markets. Neptune`s products generally come in bulk oil or capsule form and serve as a dietary supplement to consumers. Neptune`s head office is located at 545 Promenade du Centropolis, Suite 100, Laval, Quebec. Neptune respectively holds approximately 49% of the participating and voting rights of Acasti and 96% of the voting rights of NeuroBio. Through these subsidiaries, Neptune is also pursuing opportunities in the medical food and prescription drug markets. Acasti and NeuroBio respectively focus on the research and development of safe and therapeutically effective compounds for highly prevalent atherosclerotic conditions, such as cardiometabolic disorders and cardiovascular diseases, and for neurodegenerative and inflammation related conditions. Acasti`s lead prescription drug candidate is CaPre(R), a purified high omega-3 phospholipid concentrate derived from Neptune krill oil being developed to address the prevention and treatment of cardiometabolic disorders, including hypertriglyceridemia, which is characterized by abnormally high levels of triglycerides.